FDA Approved: GEFITINIB — Original Application (Natco Pharma USA LLC)

View source ↗

Summary

The FDA approved Natco Pharma USA LLC's original ANDA for Gefitinib, enabling a generic version of the cancer drug to enter the market.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Gefitinib (Gefitinib)

Snippet

ORIG AP for GEFITINIB (GEFITINIB)